Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib helped improve hair, eyebrow, and eyelash growth in alopecia areata patients.

Ruxolitinib can help regrow hair in severe alopecia areata.

Oxyresveratrol promotes hair growth and may help treat hair loss.

5-alpha reductase inhibitors can cause sexual, neurologic, endocrine, and cardiovascular side effects, but these are rare and usually stop after ending treatment.

Deuruxolitinib significantly helps regrow scalp hair in adults with moderate to severe alopecia areata.

Tofacitinib is a potential alternative treatment for alopecia totalis, especially in patients with a shorter duration of the condition and more preserved hair follicles, but the overall response rate is low.

Abrocitinib may effectively treat stubborn alopecia universalis.

The synthetic retinoid EC23 thickens skin and promotes hair growth more effectively and with a lower dose than natural retinoids.

Analog 23 is a promising compound for prostate cancer treatment.

Topical calcitriol appears safe and may reduce hair loss during chemotherapy.

MK-0773 is a moderate inhibitor of the SRD5A2 enzyme.

Inhibiting retinoic acid activates WNT signaling, potentially aiding hair disorder and skin cancer treatments.

Erlotinib can cause acne-like skin issues, needing early treatment and possible dosage adjustments.

BRAF inhibitors for melanoma often cause skin side effects, but they can be managed with proper care.

Rezpegaldesleukin shows promise for treating severe alopecia areata.

Dutasteride may help treat prostate cancer by causing cancer cells to shrink and die.

CTP-543 significantly improved eyebrow and eyelash regrowth and patient satisfaction in adults with alopecia areata.

EX104 effectively promotes hair growth and regenerates follicles in androgenetic alopecia.

GT20029 showed some hair growth improvement, but longer studies are needed for better results.

Isotretinoin and tazarotene help treat acne, while minoxidil and finasteride promote hair growth.

Tofacitinib helped a woman regrow hair with no major side effects.

Tofacitinib may be effective for treating hair loss caused by alopecia areata that doesn't respond to other treatments.

Topical minoxidil improves hair loss in 80% of women with breast cancer undergoing endocrine therapy.

BI 2536 had limited effectiveness against several advanced cancers and caused significant side effects.

Bicalutamide may improve hair growth in postmenopausal women with mild side effects.

EGFR cancer drugs often cause a rash, which can lead to distress and isolation, but may also improve outcomes for some cancer patients. Current treatments for the rash are limited, but a compound called menadione shows promise.

RU 58841 may treat acne, hair loss, and excessive hair growth.

Baricitinib effectively promotes regrowth of eyebrows and eyelashes in alopecia areata patients.